$AMED (Amedisys Inc.)

$AMED {{ '2016-02-11T12:23:40+0000' | timeago}} • Announcement

Home health provider $AMED said it agreed to acquire Associated Home Care, a private-duty home healthcare agency based in North Andover, Massachusetts. Under the terms of the agreement, the company will acquire 100% of the ownership interests in Associated Home Care for $28MM. The transaction is expected to close on March 1, 2016.

$ABBV {{ '2017-07-21T16:09:32+0000' | timeago}} • Announcement

$ABBV received positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for Humira (adalimumab) for the treatment of chronic non-infectious anterior uveitis in pediatric patients. Uveitis is an inflammation of the uvea, which includes the iris, choroid, and the ciliary body in eye.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$PRGO {{ '2017-07-17T13:30:02+0000' | timeago}} • Announcement

$PRGO received final approval from the FDA for its AB rated Abbreviated New Drug Application referencing $ABBV's Androgel Topical Gel, 1.62% packets. The gel is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

$PRSC {{ '2017-07-07T15:47:58+0000' | timeago}} • Announcement

$PRSC has appointed Jeff Felton as the CEO of its subsidiary LogistiCare Solutions, LLC, effective July 10, 2017. He most recently served as President of McKesson Connected Care and Analytics and he has also worked at Cardinal Health, Baxter Healthcare and Procter and Gamble.

$EVHC {{ '2017-07-05T14:28:39+0000' | timeago}} • Announcement

$EVHC unit Envision Physician Services acquired multi-specialty group Infinity Healthcare, Inc., headquartered in Wisconsin. No other terms were disclosed.

$EVHC {{ '2017-07-05T13:18:41+0000' | timeago}} • Announcement

Healthcare services provider $EVHC said its subsidiary Envision Physician Services has acquired Northside Emergency Associates, an emergency medicine physician group practice. The company did not disclose financial details of the transaction.

$MMM {{ '2017-06-30T15:31:24+0000' | timeago}} • Announcement

$MMM completed the sale of its tolling and automated license/number plate recognition business to Neology, which is a subsidiary of SMARTRAC, a portfolio company managed by One Equity Partners. The impact of the transaction will be neutral to both 2Q17 and full-year 2017 GAAP EPS.

$EVHC {{ '2017-06-30T12:14:40+0000' | timeago}} • Announcement

Healthcare firm $EVHC said the outstanding shares of its 5.25% series A-1 mandatory convertible preferred stock will automatically convert into common shares, effective  July 3, 2017. Each share of the preferred stock, unless previously converted, will automatically convert into 1.8141 shares of the common stock.

$USPH {{ '2017-06-29T19:00:45+0000' | timeago}} • Webcast

$USPH estimates its corporate office costs, as a percentage of revenue, will be in the upper 8% to lower 9% range this year. The company said its recently adopted accounting standard and a change in the value of restricted share grants resulted in tax credit in 1Q17. The current focus is on acquisition-related opportunities to sustain growth.

$USPH {{ '2017-06-29T18:56:30+0000' | timeago}} • Webcast

$USPH expects its newly-launched analytics tool to bear good fruit as the year progresses. The company intends to continue consolidation of its smaller partnerships. The visits per clinic per day progressed sequentially in 1Q17 and has continued to progress well.

$ABT {{ '2017-06-29T17:53:11+0000' | timeago}} • Announcement

$ABT announced the Health Canada license of its FreeStyle Libre Flash Glucose Monitoring System, a glucose sensing technology for adults with diabetes. This system eliminates the need for routine finger sticks or finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days.

Recent Transcripts

ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
USPH (US Physical Therapy Inc.)
Thursday, June 29 2017 - 2:30pm
PMC (PharMerica Corporation)
Wednesday, May 10 2017 - 2:00pm
PRSC (Providence Service Corp.)
Wednesday, May 10 2017 - 12:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
PETS (PetMed Express, Inc.)
Monday, May 8 2017 - 12:30pm
DVCR (Diversicare Healthcare Services Inc.)
Friday, May 5 2017 - 12:30pm
ZGNX (Zogenix, Inc.)
Thursday, May 4 2017 - 8:30pm
LHCG (LHC Group, Inc.)
Thursday, May 4 2017 - 3:00pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
ABC (AmerisourceBergen Corporation)
Thursday, May 4 2017 - 12:30pm
AMED (Amedisys Inc.)
Wednesday, May 3 2017 - 3:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
AET (Aetna Inc.)
Tuesday, May 2 2017 - 12:30pm
CVS (CVS Health Corporation)
Tuesday, May 2 2017 - 12:30pm
ZIOP (ZIOPHARM Oncology, Inc.)
Monday, May 1 2017 - 8:30pm
TVTY (Tivity Health, Inc.)
Thursday, April 27 2017 - 9:00pm
CHE (Chemed Corp.)
Thursday, April 27 2017 - 2:00pm
ABBV (AbbVie Inc.)
Thursday, April 27 2017 - 1:00pm

AlphaGraphics you may like